Article
T1799A BRAF mutations in conjunctival melanocytic lesions.
Investigative ophthalmology & visual science - 1 Sept 2005
Goldenberg-Cohen Nitza, Cohen Yoram, Rosenbaum Eli, Herscovici Zvi, Chowers Itay, Weinberger Dov, Pe'er Jacob, Sidransky David
Abstract excerpt
PURPOSE: To gain a better understanding of the molecular events leading to the development of conjunctival melanocytic lesions and conjunctival melanoma, this study was conducted to investigate the presence of T1799A BRAF oncogenic mutation in these lesions. METHODS: Forty-eight surgically excised conjunctival melanocytic lesions from 48 patients were examined for the presence of the BRAF T1799A mutation....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.